CLINICAL_TRIALS
trial_result
· 2019-10-23
Clinical Trial Update: Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy [Phase 3]
Summary
A Phase 3 trial evaluating denosumab (Prolia) for acute Charcot neuroarthropathy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Western University of Health Sciences | Conditions: Charcot Joint of Foot | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23